Fluoroquinolones, surgery in multidrug-resistant TB

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1445, 2004-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multidrug-resistant TB `a curable disease'

By  

Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Multidrug-resistant TB gets backing from drug giant

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Strategies to fight multidrug resistant TB

By  

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

QSAR Based Design of New Antitubercular Compounds: Improved Isoniazid Derivatives Against Multidrug-Resistant TB

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-08 ,pp. : 4427-4454

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment and Prevention of Multidrug-Resistant Tuberculosis

By Bastian I.   Colebunders R.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 633-661

Adis International

Access to resources Recommend Favorite